-
A descriptive study enrolled children 2-18 years of age presenting to a pediatric emergency department in Rhode Island during the months of April through December of 2006-2009.
-
Clinical laboratories in north america are increasingly switching to the newer treponemal-specific assays, such as the enzyme immunoassay (EIA) or chemiluminescence immunoassay (CIA) for syphilis testing.
-
Xigris® (drotrecogin alfa [activated]), a recombinant form of human activated protein C, received FDA approval in November 2001 for the reduction of mortality in adult patients with severe sepsis with a high risk of death.
-
Congenital toxoplasmosis occurs exclusively in infants born to mothers who acquire primary infection during their pregnancy. Unfortunately, many of these infections occur without clinical signs or symptoms, and the mothers go untreated.
-
A descriptive study enrolled children 2-18 years of age presenting to a pediatric emergency department in Rhode Island during the months of April through December of 2006-2009. Children were enrolled who had pleocytosis, defined as white blood cell count of > 8/mm3 in the cerebrospinal fluid (CSF), in the absence erythema migrans rash, cranial neuropathy, papilledema, a positive Gram stain, antibiotic use within 2 weeks, chronic
-
-
In this issue: New recommendations for HPV vaccine; guidelines for treatment of essential tremor; updates on smoking cessation drugs; and FDA actions.
-
A revision to the Jan. 10, 2011, Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents was published on Oct. 14, 2011.
-
-
The association between S. bovis group infection (particularly endocarditis) and concurrent colorectal neoplasia has been known for some time.
